Browse diseases

…ope she will take consolation from the fact that a diagnosis of melanoma in situ is associated with an overall reduced risk of death from any ca…

…00 mg every three weeks (Q3W)) in advanced NSCLC, melanoma, and head and neck squamous cell carcinoma in both immune checkpoint inhibitor (ICI)-naive and ICI-refract…

…ht junction structure and ameliorated the inflammation and ICIs colitis. Furthermore, a pharmacological screen identified the small mol…

…e in cases of breast, head and neck, gynaecological cancers and melanoma. It is estimated that 50% of recurrences of gynaecological canc…

…solid tumors, including breast,5 lung,6 colorectal cancers7 and melanoma,8 where PIR has been implicated in promoting cell proliferation…

… potentially influencing pathways involved in susceptibility to melanoma.1…

…ing autoimmune disease. Pembrolizumab was mainly prescribed for lung cancer (59%) and melanoma (27%), with 14% other malignancies. At the t…

…with melanoma, 100 with non-small-cell lung cancer, and 11 with renal cancer. Reduced dose pembrolizumab was prescribed in 82% (192 out of 2…

… (including OV-BYTE, chemotherapy, and PD-1 ICB) in both murine colorectal cancer model and patient-derived colorectal cancer organoid.Results We…

…ve patients participated in the study, consisting of eight with breast cancer and four with melanoma. Of these patients, nine were female and…

…he current landscape and growing potential of cell therapies in sarcomas, including TCR-T, chimeric antigen receptor-T cells, tumor-infi…

…read to the gastrointestinal tract are lung, breast, kidney and melanoma. Symptoms can vary, but patients are usually asymptomatic, pres…